Skip to content

Clinical trials

Diabetic Nephropathies trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Country / region: Hungary Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20122
20131
20142
20152
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
AstraZeneca2
Tanabe Pharma Corporation2
Amgen1
Aptabio Therapeutics, Inc.1
Eli Lilly and Company1
Inversago Pharma Inc.1
Janssen Research & Development, LLC1
NephroGenex, Inc.1
Relypsa, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies14
Diabetes Mellitus, Type 29
Renal Insufficiency, Chronic6
Kidney Diseases3
Diabetes Mellitus, Type 12
Kidney Failure, Chronic2
Diabetes Mellitus1
Heart Failure1
Hyperkalemia1
Hypertension1

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.